Moclobemide

DRUG3 trials

Sponsors

Jed E. Rose, Hannover Medical School, China Medical University Hospital

Conditions

AddictionAnxiety DisordersDementiaDepressionNicotine DependencePsychosomatic DisordersSchizophrenia

Phase 2

Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers

CompletedNCT01926626

Jed E. RoseNicotine Dependence

Start: 2013-09-30End: 2014-10-31Updated: 2017-08-23

Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer

TerminatedNCT03010761

China Medical University HospitalAddiction

Start: 2016-01-14End: 2018-01-31Updated: 2019-07-24

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28